Iris Acquisition II Corp Unit (IRAB.U)

Iris Acquisition II Corp Unit is a listed hybrid security on the NYSE, classified as a debt/equity composite unit. The underlying issuer, Iris Acquisition Corp II, is a special purpose company with no significant operating business. Its stated objective is to pursue a business combination through a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more businesses. The company was incorporated in 2025 and is based in Dubai, United Arab Emirates.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Free Cash Flow / Net Income
NYSE-IRAB.U
Not available
Not available
Not available
Good
0.0%
230.4 M
229.4 M
0.0%
64.5%
0.0%
Valuation • Fair Value

Iris Acquisition II Corp Unit (NYSE-IRAB.U) Fair Value by Valuation Model

No usable valuation estimate is currently available for Iris Acquisition II Corp Unit (NYSE-IRAB.U); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Iris Acquisition II Corp Unit (NYSE-IRAB.U). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Iris Acquisition II Corp Unit (NYSE-IRAB.U) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

0

Weak quality score that deserves closer review.

FCF / Net Income

0.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Iris Acquisition II Corp Unit (NYSE-IRAB.U). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Iris Acquisition II Corp Unit (NYSE-IRAB.U)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Iris Acquisition II Corp Unit (NYSE-IRAB.U). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Iris Acquisition II Corp Unit (NYSE-IRAB.U) Stock FAQ

Data-supported answers about Iris Acquisition II Corp Unit (NYSE-IRAB.U), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Good
Current financial-health read

A reliable fair value estimate is not currently available for Iris Acquisition II Corp Unit (NYSE-IRAB.U). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Iris Acquisition II Corp Unit (NYSE-IRAB.U) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Iris Acquisition II Corp Unit (NYSE-IRAB.U).

The current market capitalization listed for Iris Acquisition II Corp Unit is 230.4 M.

The current enterprise value listed for Iris Acquisition II Corp Unit is 229.4 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Iris Acquisition II Corp Unit is NYSE-IRAB.U, and the stock is listed on NYSE.

Iris Acquisition II Corp Unit (NYSE-IRAB.U) is listed on NYSE.

The current debt-to-total-capital ratio listed for Iris Acquisition II Corp Unit is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Iris Acquisition II Corp Unit is 64.5%. Free float helps investors understand how much of the share base is available for public trading.